NCT03899792 2026-01-06LIBRETTO-121Eli Lilly and CompanyPhase 1/2 Active not recruiting36 enrolled 13 charts 2 FDA
NCT04512430 2025-04-02Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated PatientsFundación GECPPhase 2 Terminated4 enrolled 9 charts
NCT02904954 2023-10-11Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage I, II and IIIA Non-small Cell Lung CancerWeill Medical College of Cornell UniversityPhase 2 Completed60 enrolled 12 charts
NCT01999985 2020-11-27Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)H. Lee Moffitt Cancer Center and Research InstitutePhase 1 Completed25 enrolled 10 charts